TOTAL ANTIBODY TO HEPATITIS C VIRUS (ANTI-HCV) - ANVISA Registration 81325990114

Access comprehensive regulatory information for TOTAL ANTIBODY TO HEPATITIS C VIRUS (ANTI-HCV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 81325990114 and manufactured by ACRO BIOTECH, INC. (MONTCLAIR). The registration is held by QR CONSULTING, IMPORTACAO E DISTRIBUICAO DE PRODUTOS MEDICOS LTDA with validity until Mar 16, 2030.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including BIO-RAD, QUIBASA QUÍMICA BÁSICA LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
81325990114
2 Related Devices
Registration Details
ANVISA Registration Number: 81325990114
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Registration Details

81325990114

25351513943201967

19933144000129

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Mar 16, 2020

16/03/2030

09/18/2025 19:00:01

Registration Details

81325990114

25351513943201967

19933144000129

Dates and Status

Mar 16, 2020

16/03/2030

09/18/2025 19:00:01